Privi Speci.

Why is Privi Speciality Chemicals Ltd falling/rising?

As of 30-Jul, Privi Speciality Chemicals Ltd's stock price is Rs 3,568.10, down 3.46%, following four days of gains and underperforming its sector. Despite strong long-term growth, current market sentiment is negative, leading to a short-term pullback.

As of 30-Jul, Privi Speciality Chemicals Ltd is experiencing a decline in its stock price, currently at Rs 3,568.10, which reflects a change of -128.0 (-3.46%). This drop can be attributed to several factors. Firstly, the stock has underperformed its sector by -1.87% today, indicating weaker performance compared to its peers. Additionally, the stock has fallen after four consecutive days of gains, suggesting a trend reversal.<BR><BR>The stock also touched an intraday low of Rs 3,502.9, marking a significant decrease of -5.23%. Despite being close to its 52-week high, at only 4.88% away from Rs 3,775.7, the current price movement indicates a short-term pullback. Furthermore, the weighted average price shows that more volume was traded near the low price, which may reflect selling pressure.<BR><BR>While the company has shown healthy long-term growth with a 29.73% annual increase in operating profit and has consistently reported positive results over the last 12 quarters, the immediate market sentiment appears to be negative, contributing to the stock's decline.

Which are the latest news on Privi Speci.?

Should I buy, sell or hold Privi Speciality Chemicals Ltd?

When is the next results date for Privi Speciality Chemicals Ltd?

The next results date for Privi Speciality Chemicals Ltd is July 30, 2026.

The next results date for Privi Speciality Chemicals Ltd is scheduled for July 30, 2026.

How big is Privi Speci.?

As of 10th June, Privi Speciality Chemicals Ltd has a market capitalization of 12,336.00 Cr, with recent net sales of 2,563.68 Cr and net profit of 327.53 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Privi Speciality Chemicals Ltd has a market capitalization of 12,336.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 2,563.68 Cr, while the sum of Net Profit for the same period is 327.53 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 1,103.43 Cr, and Total Assets amount to 2,790.51 Cr.

Who are in the management team of Privi Speci.?

The management team of Privi Speci includes Mahesh Babani (Chairman & Managing Director), D B Rao (Executive Director), and several Non-Executive & Independent Directors, along with a Company Secretary. They are responsible for the company's strategic direction and regulatory compliance.

The management team of Privi Speci includes the following members:<BR><BR>1. **Mahesh Babani** - Chairman & Managing Director<BR>2. **D B Rao** - Executive Director<BR>3. **Rajesh Budhrani** - Non-Executive & Independent Director<BR>4. **P R Barpande** - Non-Executive & Independent Director<BR>5. **Anurag Surana** - Non-Executive & Independent Director<BR>6. **D T Khilnani** - Non-Executive & Independent Director<BR>7. **Anuradha Eknath Thakur** - Independent Director<BR>8. **Ashwini Saumil Shah** - Company Secretary & Compliance Officer<BR>9. **Hemang Manhar Gandhi** - Additional Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and ensuring compliance with regulations.

Who are the peers of the Privi Speci.?

Peers of Privi Speci. include Aether Industri., Anupam Rasayan, Fine Organic, BASF India, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Clean Science, Elantas Beck, and Balaji Amines. Privi Speci. has below average capital structure and average growth, with a 1-year return of 40.53%.

Peers: The peers of Privi Speci. are Aether Industri., Anupam Rasayan, Fine Organic, BASF India, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Clean Science, Elantas Beck, and Balaji Amines.<BR><BR>Quality Snapshot: Excellent management risk is observed at Fine Organic and Clean Science, while Good management risk is found at BASF India, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Elantas Beck, and Privi Speci. Average management risk is noted at Aether Industri. and Balaji Amines, and Below Average management risk is present at Anupam Rasayan. In terms of Growth, Excellent growth is seen at Fine Organic and Average growth at Aether Industri., Anupam Rasayan, Privi Speci., and the rest. Below Average growth is noted at BASF India, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Clean Science, Elantas Beck, and Balaji Amines. For Capital Structure, Excellent capital structure is observed at Aether Industri., Fine Organic, BASF India, Vinati Organics, Jubilant Ingrev., Alkyl Amines, and Balaji Amines, while Privi Speci. has a Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aether Industri. at 43.94%, while the lowest is Clean Science at -50.53%. Privi Speci.'s 1-year return is 40.53%, which is significantly higher than Clean Science but lower than Aether Industri. Additionally, BASF India, Vinati Organics, Jubilant Ingrev., Clean Science, and Elantas Beck all have negative six-month returns.

What does Privi Speci. do?

Privi Speciality Chemicals Ltd is a leading Indian manufacturer and exporter of aroma and fragrance chemicals, with recent net sales of ₹722 Cr and a net profit of ₹94 Cr as of March 2026. The company has a market cap of ₹12,336 Cr and key financial metrics include a P/E ratio of 38.00 and a return on equity of 23.19%.

Overview:<BR>Privi Speciality Chemicals Ltd is India's leading manufacturer, supplier, and exporter of aroma and fragrance chemicals, operating in the specialty chemicals industry within the small-cap market segment.<BR><BR>History:<BR>The company was incorporated in an unspecified year and has maintained its status as a prominent player in the aroma chemicals sector. The latest quarterly results reported are for March 2026, showcasing net sales and profits.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 722 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 94 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 12,336 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 38.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.15% <BR>Debt-Equity: 0.64 <BR>Return on Equity: 23.19% <BR>Price to Book: 8.76 <BR><BR>Contact Details:<BR>Address: Plot No A-71 TTC, Thane-Belapur Road Navi Mumbai Maharashtra : 400709 <BR>Tel: 91-022-27783040/27783041 <BR>Email: cs@adifinechem.com/sales@privi.co.i <BR>Website: http://www.fairchem.in

Are Privi Speciality Chemicals Ltd latest results good or bad?

Privi Speciality Chemicals Ltd's Q4 FY26 results are strong, with a net profit increase of 20.14% QoQ and 40.86% YoY, alongside revenue growth of 19.33% QoQ and 17.60% YoY. However, a significant drop in promoter stake from 69.89% to 60.60% has raised concerns, leading to some caution despite the overall positive financial performance.

Privi Speciality Chemicals Ltd's latest results for Q4 FY26 can be considered quite strong overall. The company reported a net profit of ₹93.70 crore, marking a significant increase of 20.14% quarter-on-quarter (QoQ) and 40.86% year-on-year (YoY). Revenue also saw impressive growth, reaching ₹721.52 crore, which is up 19.33% QoQ and 17.60% YoY, indicating robust demand and operational efficiency.<BR><BR>The operating margin remained stable at 24.98%, and the profit after tax (PAT) margin improved to 13.04%, reflecting effective cost management and operational leverage. Additionally, the company's return on capital employed (ROCE) surged to 21.72%, nearly doubling from its five-year average, which highlights significant improvements in capital productivity.<BR><BR>However, there are concerns regarding a notable reduction in promoter stake from 69.89% to 60.60%, which has raised questions about management confidence and led to a selloff in the stock following the results. Despite this, the overall financial performance demonstrates strong momentum and operational excellence, making the results largely positive, albeit with some caution due to the promoter stake issue.

How has been the historical performance of Privi Speci.?

Privi Speci. has shown significant growth in net sales and profits, with net sales increasing from 1,276.56 Cr in March 2021 to 2,101.19 Cr in March 2025, and profit after tax rising from 21.28 Cr to 184.75 Cr during the same period, indicating strong financial performance and operational efficiency.

Answer:<BR>The historical performance of Privi Speci. shows a significant upward trend in net sales and profits over the years, culminating in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Privi Speci. has demonstrated robust growth in net sales, increasing from 1,276.56 Cr in March 2021 to 2,101.19 Cr in March 2025. This growth is reflected in the total operating income, which rose from 1,324.11 Cr in March 2020 to 2,101.19 Cr in March 2025. The company's operating profit (PBDIT) also showed a positive trend, climbing from 243.51 Cr in March 2020 to 474.16 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged from 31.04 Cr in March 2023 to 254.52 Cr in March 2025, while profit after tax increased from 21.28 Cr to 184.75 Cr in the same period. The earnings per share (EPS) saw a remarkable rise from 5.69 in March 2023 to 47.88 in March 2025. On the balance sheet, total assets grew from 1,383.69 Cr in March 2020 to 2,790.51 Cr in March 2025, with total liabilities also increasing from 1,128.37 Cr to 2,790.51 Cr. The company maintained a stable equity capital of 39.06 Cr throughout the years. Cash flow from operating activities improved significantly, reaching 281.00 Cr in March 2025, despite cash flow from investing activities remaining negative. Overall, Privi Speci. has shown a strong financial performance with increasing revenues, profits, and asset growth over the years.

Is Privi Speci. technically bullish or bearish?

As of October 7, 2025, the trend has shifted to bullish with moderate strength, supported by positive monthly MACD and moving averages, although caution is advised due to mildly bearish weekly indicators.

As of 7 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include the monthly MACD being bullish, daily moving averages indicating bullish momentum, and both weekly and monthly Bollinger Bands showing bullish signals. However, the weekly MACD and KST are mildly bearish, suggesting some caution. Overall, the strong performance relative to the Sensex, particularly in the 1Y and 5Y periods, supports the bullish outlook.

Is Privi Speci. overvalued or undervalued?

As of September 5, 2025, Privi Speci. is considered very expensive and overvalued with a PE Ratio of 40.97 and an EV to EBITDA of 20.50, despite outperforming the Sensex with a 1-year return of 53.31%.

As of 5 September 2025, the valuation grade for Privi Speci. has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently considered overvalued. Key ratios include a PE Ratio of 40.97, an EV to EBITDA of 20.50, and a Price to Book Value of 8.08, all of which suggest that the stock is trading at a premium compared to its earnings and assets.<BR><BR>In comparison to its peers, Privi Speci. has a higher PE Ratio than Godrej Industries, which stands at 40.09, and significantly lower than Solar Industries, which is at 99.93. The PEG Ratio of 0.52 indicates potential growth relative to its price, but the overall valuation metrics suggest that the stock is not justified at its current price level. Notably, Privi Speci. has outperformed the Sensex with a 1-year return of 53.31% compared to the Sensex's decline of 1.81%, yet this strong performance does not mitigate the concerns regarding its high valuation.

Who are the top shareholders of the Privi Speci.?

The top shareholders of Privi Speci. include Vivira Investment And Trading Private Limited with 39.67%, followed by Banbridge Limited at 6.1%, and individual investors holding 14.16%. Additionally, mutual funds own 1.42%, and foreign institutional investors hold 0.4%, with no pledged promoter holdings reported.

The top shareholders of Privi Speci. include several key players. The majority shareholders are the promoters, with Vivira Investment And Trading Private Limited holding the largest stake at 39.67%. In terms of public shareholders, Banbridge Limited is the highest, owning 6.1%. Additionally, individual investors collectively hold 14.16% of the company. Mutual funds have a presence with 1.42% held by one scheme, while foreign institutional investors (FIIs) hold 0.4% across 37 different entities. Notably, there are no pledged promoter holdings reported.

What is the bonus history of the Privi Speci.?

Privi Speciality Chemicals Ltd has issued bonuses in the following ratios: 1:10 on July 9, 2014 (record date July 10, 2014), 1:10 on July 3, 2013 (record date July 4, 2013), and 1:5 on July 12, 2012 (record date July 16, 2012).

Privi Speciality Chemicals Ltd has a history of bonus issues as follows:<BR><BR>1. On July 9, 2014, the company announced a bonus issue in the ratio of 1:10, with the record date being July 10, 2014.<BR>2. Prior to that, on July 3, 2013, there was another bonus issue also in the ratio of 1:10, with the record date on July 4, 2013.<BR>3. Additionally, on July 12, 2012, the company issued a bonus in the ratio of 1:5, with the record date being July 16, 2012.<BR><BR>This reflects the company's approach to rewarding its shareholders through bonus shares over the years.

Has Privi Speci. declared dividend?

Privi Speciality Chemicals Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of July 24, 2024. The company has shown strong price returns over various periods, despite a low dividend yield of 0.07%.

Privi Speciality Chemicals Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 24 Jul 24<BR><BR>Dividend Yield: 0.07%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 22.38%, with a dividend return of 0%, resulting in a total return of 22.38%.<BR><BR>Over the past year, the price return was 92.08%, the dividend return was 0.17%, leading to a total return of 92.25%.<BR><BR>In the 2-year period, the price return stood at 97.83%, while the dividend return was 0.18%, culminating in a total return of 98.01%.<BR><BR>For the 3-year period, the price return was 98.84%, with a dividend return of 0.38%, resulting in a total return of 99.22%.<BR><BR>In the last 4 years, the price return was 120.34%, the dividend return was 0.55%, which brought the total return to 120.89%.<BR><BR>Finally, over the 5-year period, the price return reached 371.26%, with a dividend return of 1.28%, leading to a total return of 372.54%.<BR><BR>Overall, Privi Speciality Chemicals Ltd has declared a dividend, albeit with a relatively low dividend yield, while demonstrating strong price returns across all periods, indicating robust growth in its stock value.